{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:48:46Z","timestamp":1694634526752},"reference-count":34,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.patbio.2008.11.005","type":"journal-article","created":{"date-parts":[[2009,2,4]],"date-time":"2009-02-04T17:12:29Z","timestamp":1233767549000},"page":"536-542","source":"Crossref","is-referenced-by-count":2,"title":["Le syndrome de Willebrand acquis\u00a0: du diagnostic au traitement"],"prefix":"10.1016","volume":"57","author":[{"given":"S.","family":"Bustany","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lequerrec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Troussard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ollivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Borel-Derlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2008.11.005_bib1","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V31.6.806.806","article-title":"Acquired von Willebrand's syndrome in systemic lupus erythematosus","volume":"31","author":"Simone","year":"1968","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2008.11.005_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Acquired von Willebrand syndrome: data from an international registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2008.11.005_bib3","first-page":"111","article-title":"Le syndrome de Willebrand acquis","volume":"11","author":"Briat","year":"2005","journal-title":"Hematologie"},{"key":"10.1016\/j.patbio.2008.11.005_bib4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"The working party on von Willebrand disease classification. Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von Willebrand factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2008.11.005_bib5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V57.6.1140.1140","article-title":"The complex multimeric composition of factor VIII\/von Willebrand factor","volume":"57","author":"Ruggeri","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2008.11.005_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/s-0038-1653759","article-title":"The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability","volume":"73","author":"Verbruggen","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2008.11.005_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.10298","article-title":"Acquired von Willebrand's syndrome: a single institution experience","volume":"72","author":"Kumar","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.patbio.2008.11.005_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic senosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2008.11.005_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2169\/internalmedicine.46.6026","article-title":"Occult gastrointestinal bleeding due to acquired von Willebrand syndrome in a patient with hypertrophic obstructive cardiomyopathy","volume":"46","author":"Shimizu","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.patbio.2008.11.005_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.1999.01360.x","article-title":"Three cases of acquired von Willebrand disease associated with systemic lupus erythemosus","volume":"105","author":"Viallard","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2008.11.005_bib11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2516.1999.00340.x","article-title":"Acquired von Willebrand syndrome \u2013 report of 10 cases and review of the literature","volume":"5","author":"Nitu-Whalley","year":"1999","journal-title":"Haemophilia"},{"key":"10.1016\/j.patbio.2008.11.005_bib12","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical sgnificance of ihibitors in acquired von Willebrand syndrome","volume":"91","author":"Mohri","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2008.11.005_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1538-7836.2008.02909.x","article-title":"Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study","volume":"6","author":"Tiede","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2008.11.005_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.0007-1048.2002.03341.x","article-title":"Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome","volume":"116","author":"Casonato","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2008.11.005_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2516.2003.00750.x","article-title":"A new ELISA assay for diagnosis of acquired von Willebrand syndrome","volume":"9","author":"Siaka","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.patbio.2008.11.005_bib16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1055\/s-0037-1615752","article-title":"Pharmacokinetic studies with FVIII\/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome","volume":"85","author":"Luboshitz","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2008.11.005_bib17","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches","volume":"92","author":"Federici","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2008.11.005_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0037-1615235","article-title":"Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome","volume":"80","author":"van Genderen","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.patbio.2008.11.005_bib19","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/j.1538-7836.2005.01571.x","article-title":"Cysteine-mutations in von Willebrand factor associated with increased clearance","volume":"3","author":"Schooten","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.patbio.2008.11.005_bib20","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V64.3.614.614","article-title":"Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or begnin monoclonal gammopathies","volume":"64","author":"Mannucci","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2008.11.005_bib21","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood.V84.10.3378.3378","article-title":"Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen","volume":"84","author":"van Genderen","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2008.11.005_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.1985.tb02975.x","article-title":"IgA inhibitor to factor VIII\/von Willebrand factor","volume":"59","author":"Gralnick","year":"1985","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2008.11.005_bib23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1046\/j.1365-2141.1997.d01-2088.x","article-title":"Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells","volume":"96","author":"Tefferi","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2008.11.005_bib24","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood.V88.8.2939.bloodjournal8882939","article-title":"Shear-dependent changes in the three-dimensional structure of human von Willebrand factor","volume":"88","author":"Siedlecki","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2008.11.005_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-2003-44556","article-title":"Shear stress and von Willebrand factor in health and disease","volume":"29","author":"Tsai","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.patbio.2008.11.005_bib26","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.patbio.2008.11.005_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2516.2007.01642.x","article-title":"Hypothyroidism and acquired von Willebrand's syndrome: a systematic review","volume":"14","author":"Manfredi","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.patbio.2008.11.005_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1677\/joe.0.1540231","article-title":"Increase by tri-iodothyronine of endothelin-1, fibronectin and von Willebrand factor in cultured endothelial cells","volume":"154","author":"Baumgartner-Parzer","year":"1997","journal-title":"J Endocrinol"},{"key":"10.1016\/j.patbio.2008.11.005_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1677\/joe.0.1680427","article-title":"The biological relevance of thyroid hormone receptors in immortalized human umbilical vein endothelial cells","volume":"168","author":"Diekman","year":"2001","journal-title":"J Endocrinol"},{"key":"10.1016\/j.patbio.2008.11.005_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.20760","article-title":"Acquired von Willebrand syndrome: diagnostic problems and therapeutic options","volume":"82","author":"Eikenboom","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.patbio.2008.11.005_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00319974","article-title":"Intravenous immunoglobulin therapy: new aspects and outlook","volume":"48","author":"Imbach","year":"1984","journal-title":"Blut"},{"key":"10.1016\/j.patbio.2008.11.005_bib32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.2830230303","article-title":"In vitro effects of gammaglobulin (IgG) on human monocyte Fc receptor function. I. Effect on monocyte membrane-associated IgG and Fc receptor-dependent binding of antibody-coated platelets","volume":"23","author":"Saleh","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1016\/j.patbio.2008.11.005_bib33","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/BF00915364","article-title":"Correlation of in vitro antibody synthesis with the outcome of intravenous gamma-globulin treatment of chronic idiopathic thrombocytopenic purpura","volume":"6","author":"Bussel","year":"1986","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.patbio.2008.11.005_bib34","first-page":"143","article-title":"The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome","volume":"112","author":"Gail Macik","year":"1988","journal-title":"Arch Pathol Lab Med"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811408002824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811408002824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T02:45:34Z","timestamp":1633056334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811408002824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":34,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0369811408002824"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2008.11.005","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}